Previous close | 61.23 |
Open | 61.30 |
Bid | 61.89 x N/A |
Ask | 62.30 x N/A |
Day's range | 61.30 - 62.06 |
52-week range | 56.43 - 73.72 |
Volume | |
Avg. volume | 36 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Cognizant (NASDAQ: CTSH) today announced an agreement to provide engineering services to Gentherm (NASDAQ: THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems. Cognizant is providing systems engineering, validation, and model-based development services from Hyderabad, India, and has created a test facility to conduct research and development for Gentherm prod
As part of an expanded partnership announced last August, Cognizant (NASDAQ: CTSH) has launched the first set of healthcare large language model (LLM) solutions on Google Cloud's generative AI (genAI) technology, including the company's Vertex AI platform and Gemini models, aimed at redesigning healthcare administrative processes and improving experiences.
Cognizant (NASDAQ: CTSH) (the "Company") today announced it has signed a definitive agreement to acquire Belcan, LLC ("Belcan"), a portfolio company of AE Industrial Partners and a leading global supplier of Engineering Research & Development (ER&D) services, at a purchase price of approximately $1.3 billion in cash and stock, subject to customary adjustments.